Takeda Pharmaceutical president

TOKYO, Japan - Yasuchika Hasegawa, president of Takeda Pharmaceutical Co., speaks in an interview in Tokyo on Jan. 6, 2014.

Sample
PDF Preview

Product Code
ILEA001190784

Registered date
2014/1/06 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2014 Kyodo News

Media size
2806 × 3811 pixel

Resolution
240 dpi

Deployment size
910.04(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Infectious disease center in Bhutan

Japan International Cooperation Agency President Akihiko Tanaka delivers a speech at an inauguration ceremony for the Royal Centre for Infectious Diseases in Gidakom, Bhutan, on June 28, 2026. The center was built with Japan's foreign aid to assist in Bhutan's efforts to strengthen response to infectious diseases and enhance national health security.

Infectious disease center in Bhutan

Bhutan's Prime Minister Tshering Tobgay (L) presents a commemorative gift to Japan International Cooperation Agency President Akihiko Tanaka at an inauguration ceremony for the Royal Centre for Infectious Diseases in Gidakom, Bhutan, on June 28, 2026. The center was built with Japan's foreign aid to assist in Bhutan's efforts to strengthen response to infectious diseases and enhance national health security.

Emergency contraceptive pills

Photo taken on Feb. 2, 2026, at a pharmacy in Tokyo shows a package of NorLevo emergency contraceptive pills as Japan begins over-the-counter sales of them without age restrictions.

Spreading infectious diseases in China

People walk in Beijing on Jan. 6, 2025, wearing masks amid spreading respiratory diseases caused by human metapneumovirus or hMPV.

Kobayashi Pharmaceutical dietary supplements

File photo taken in Osaka on April 7, 2024, shows pills of "beni-koji" red yeast rice dietary supplements manufactured by Kobayashi Pharmaceutical Co. Five deaths and about 250 hospitalizations have been reported to be possibly linked to the consumption of the product.

Japan's COVID-19 treatment subsidies to end on March 31

Japanese Health, Labor and Welfare Minister Keizo Takemi (C) speaks to reporters at the parliament building in Tokyo on March 5, 2024, as he unveils a plan to terminate government subsidies for COVID-19 treatment at the end of the current fiscal year through March 31 due to a fall in the number of cases.

Anti-Alzheimer's drug lecanemab

Haruo Naito, CEO of Japanese pharmaceutical company Eisai Co., attends a press conference in Tokyo on Dec. 13, 2023, as the company's anti-Alzheimer's drug lecanemab is set to be launched on Dec. 20, following a health ministry advisory body's approval of its coverage by the Japanese public insurance scheme.

Ex-Japan top COVID-19 adviser Omi

Shigeru Omi reflects on his time as the Japanese government's top COVID-19 adviser during an interview in Tokyo on Sept. 19, 2023.

Ex-Japan top COVID-19 adviser Omi

Shigeru Omi reflects on his time as the Japanese government's top COVID-19 adviser during an interview in Tokyo on Sept. 19, 2023.

Japan remains largely masked up on 1st day of eased COVID rules

Japan's easing of coronavirus guidelines on mask-wearing had little apparent effect on Monday, with many people still opting to stick with the habit that has been entrenched for the past three years amid the pandemic. Passengers step into a shinkansen bullet train at JR Tokyo Station on March 13, 2023, while wearing face masks despite Japan on the same day easing its COVID-19 guidelines on mask-wearing.